Oral Ketorolac for Arthroscopic Rotator Cuff Repair

• Status: Unknown status
• Trial end date: 2020-01-01
• Target enrollment: 0
• Participant gender: All

Summary

1. The investigators aim to examine the use of IV and oral ketorolac as an adjunctive agent to the standard of care pain protocol for postoperative pain control following arthroscopic rotator cuff repair.

2. The investigators hypothesize that the use of IV and oral ketorolac in addition to the standard of care pain protocol will reduce postoperative opioid consumption following arthroscopic rotator cuff repair.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Hospitals Cleveland Medical Center
• Treatments: Ketorolac; Ketorolac Tromethamine

Criteria

Inclusion Criteria

1. Patients between the ages of 18 and 89 years old, male or female

2. Patients undergoing primary shoulder arthroscopic rotator cuff repair

Exclusion Criteria

1. Patients below the age of 18 or above the age of 89

2. Illiterate or non-English speaking patients

3. Patients with contraindications to Ketorolac

4. History of alcohol of drug abuse

5. Chronic use of analgesic or psychotropic drugs

6. Known peptic ulcer disease or bleeding diathesis

7. Renal dysfunction